tiprankstipranks
Trending News
More News >
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT

Corcept Therapeutics (CORT) Revenue

Compare
1,295 Followers

Corcept Therapeutics Revenue

Corcept Therapeutics had a revenue of 202.13M in the quarter ending Dec 31, 2025, with -2.66%. This bring the company's revenue in the last twelve months to 761.41M, Decreased 2.73%. In the fiscal year ending Dec 31, 2025, Corcept Therapeutics had annual revenue of 761.41M with 12.79% growth.
Revenue (ttm)
761.41M
Revenue Growth
17.92%
P/S Ratio
4.73
Revenue/Employee
$1,522,814
Employees
500
Market Cap
$3.60B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
761.41M86.37M+12.79%
Dec 31, 2024
675.04M192.66M+39.94%
Dec 31, 2023
482.38M80.52M+20.04%
Dec 31, 2022
401.86M35.88M+9.80%
Dec 31, 2021
365.98M12.10M+3.42%
Dec 31, 2020
353.87M47.39M+15.46%
Dec 31, 2019
306.49M55.24M+21.99%
Dec 31, 2018
251.25M92.05M+57.82%
Dec 31, 2017
159.20M